NasdaqGM - Nasdaq Real Time Price USD
Candel Therapeutics, Inc. (CADL)
5.39
+0.38
+(7.68%)
At close: May 13 at 4:00:02 PM EDT
5.49
+0.09
+(1.76%)
After hours: May 13 at 7:58:37 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,339,389 | 6 |
| Sales | 395,701 | 20 |
| Net Shares Purchased (Sold) | 943,688 | 26 |
| Total Insider Shares Held | 10.61M | -- |
| % Net Shares Purchased (Sold) | 9.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TAK PAUL PETER Chief Executive Officer | Sale at price 8.77 - 9.00 per share. | Direct | 229,624 | Mar 19, 2025 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 8.76 per share. | Direct | 396,995 | Mar 18, 2025 |
| BARONE FRANCESCA Officer | Sale at price 8.76 per share. | Direct | 281,673 | Mar 18, 2025 |
| NICHOLS WILLIAMS GARRETT Officer | Conversion of Exercise of derivative security at price 1.29 - 3.75 per share. | Direct | 35,127 | Mar 18, 2025 |
| BARONE FRANCESCA Officer | Conversion of Exercise of derivative security at price 1.55 per share. | Direct | 27,900 | Mar 18, 2025 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 8.82 per share. | Direct | 275,947 | Mar 17, 2025 |
| SCHOCH CHARLES Chief Financial Officer | Sale at price 8.83 per share. | Direct | 44,169 | Mar 17, 2025 |
| TYAGARAJAN SESHU Chief Technology Officer | Conversion of Exercise of derivative security at price 8.83 per share. | Direct | 176,600 | Mar 17, 2025 |
| TYAGARAJAN SESHU Chief Technology Officer | Conversion of Exercise of derivative security at price 1.29 per share. | Direct | 25,800 | Mar 17, 2025 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 7.22 per share. | Direct | 75,342 | Jan 15, 2025 |
| TAK PAUL PETER Chief Executive Officer | Sale at price 7.22 per share. | Direct | 156,811 | Jan 15, 2025 |
| BARONE FRANCESCA Officer | Sale at price 7.22 per share. | Direct | 97,783 | Jan 15, 2025 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 7.22 per share. | Direct | 103,476 | Jan 15, 2025 |
| SCHOCH CHARLES Chief Financial Officer | Sale at price 7.22 per share. | Direct | 68,717 | Jan 15, 2025 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 8.22 per share. | Direct | 88,749 | Jan 8, 2025 |
| TAK PAUL PETER Chief Executive Officer | Sale at price 8.22 per share. | Direct | 173,996 | Jan 8, 2025 |
| BARONE FRANCESCA Officer | Sale at price 8.22 per share. | Direct | 112,367 | Jan 8, 2025 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 8.22 per share. | Direct | 119,534 | Jan 8, 2025 |
| SCHOCH CHARLES Chief Financial Officer | Sale at price 8.22 per share. | Direct | 81,944 | Jan 8, 2025 |
| MANNING PAUL B. Director | Purchase at price 6.00 per share. | Indirect | 7,500,000 | Dec 16, 2024 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 4.56 per share. | Direct | 63,482 | Nov 29, 2024 |
| TAK PAUL PETER Chief Executive Officer | Sale at price 4.56 per share. | Direct | 222,527 | Nov 29, 2024 |
| BARONE FRANCESCA Officer | Sale at price 4.56 per share. | Direct | 100,592 | Nov 29, 2024 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 4.56 per share. | Direct | 92,898 | Nov 29, 2024 |
| TAK PAUL PETER Chief Executive Officer | Conversion of Exercise of derivative security at price 1.55 per share. | Direct | 19,995 | Nov 21, 2024 |
| AGUILAR-CORDOVA ESTUARDO Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.02 - 6.05 per share. | Direct | 243,834 | Oct 15, 2024 |
| AGUILAR-CORDOVA ESTUARDO Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.85 - 7.01 per share. | Direct | 242,642 | Oct 3, 2024 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 6.47 per share. | Direct | 70,390 | Jul 17, 2024 |
| TAK PAUL PETER Chief Executive Officer | Sale at price 6.47 per share. | Direct | 145,815 | Jul 17, 2024 |
| BARONE FRANCESCA Officer | Sale at price 6.47 per share. | Direct | 90,947 | Jul 17, 2024 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 6.47 per share. | Direct | 96,125 | Jul 17, 2024 |
| SCHOCH CHARLES Chief Financial Officer | Sale at price 6.47 per share. | Direct | 63,975 | Jul 17, 2024 |
| NICHOLS WILLIAMS GARRETT Officer | Sale at price 5.97 per share. | Direct | 58,354 | Jul 11, 2024 |
| TAK PAUL PETER Chief Executive Officer | Sale at price 5.97 per share. | Direct | 121,218 | Jul 11, 2024 |
| BARONE FRANCESCA Officer | Sale at price 5.97 per share. | Direct | 75,534 | Jul 11, 2024 |
| TYAGARAJAN SESHU Chief Technology Officer | Sale at price 5.97 per share. | Direct | 79,625 | Jul 11, 2024 |
| SCHOCH CHARLES Chief Financial Officer | Sale at price 5.97 per share. | Direct | 53,145 | Jul 11, 2024 |
| AMELLO JASON A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 24, 2023 |
| NICHOLS WILLIAMS GARRETT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 24, 2023 |
| TAK PAUL PETER Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 24, 2023 |
| BARONE FRANCESCA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 24, 2023 |
| TYAGARAJAN SESHU Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 24, 2023 |
Related Tickers
CAPR Capricor Therapeutics, Inc.
7.30
+2.67%
MIST Milestone Pharmaceuticals Inc.
1.1900
-0.83%
ATRA Atara Biotherapeutics, Inc.
6.68
+3.25%
FDMT 4D Molecular Therapeutics, Inc.
3.2700
-1.51%
REPL Replimune Group, Inc.
7.41
-5.73%
ALT Altimmune, Inc.
5.76
-4.16%
VNDA Vanda Pharmaceuticals Inc.
3.9800
-1.24%
ANNX Annexon, Inc.
1.7500
-1.13%
MDGL Madrigal Pharmaceuticals, Inc.
295.36
-1.80%
TSHA Taysha Gene Therapies, Inc.
2.3400
+0.86%